WuXi Biologics (Cayman) Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - WuXi Biologics (Cayman) Inc

Watchlist Manager

Watchlist

Price: 33.4 HKD 3.15% Market Closed

Market Cap: HK$138.2B

	WuXi Biologics (Cayman) Inc HKEX:2269	CN
F	Frontline Ltd NYSE:FRO	BM
V	Valtecne SpA MIL:VLT	IT
	Canadian National Railway Co TSX:CNR	CA
	Murata Manufacturing Co Ltd TSE:6981	JP
	JB Hi-Fi Ltd ASX:JBH	AU
	Natural Grocers By Vitamin Cottage Inc NYSE:NGVC	US
	En Japan Inc TSE:4849	JP
	Nov Inc NYSE:NOV	US
	Ningbo Tuopu Group Co Ltd SSE:601689	CN
C	Clemondo Group AB (publ) STO:CLEM	SE
	Endeavor Group Holdings Inc NYSE:EDR	US
	Arko Corp. NASDAQ:ARKO	US
	Chandra Asri Petrochemical Tbk PT IDX:TPIA	ID
N	Nouveau Holdings Ltd OTC:NHLI	US

Profitability Summary

WuXi Biologics (Cayman) Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

46%

Sustainable 3Y Average Gross Margin

42%

Gross Margin is Increasing

44% > 46%

Exceptional Operating Margin

32%

Sustainable 3Y Average Operating Margin

27%

Operating Margin is Increasing

30% > 32%

Healthy Net Margin

23%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

29% > 23%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.